Martek Biosciences Corporation has posted a fall in half-year profits thanks to rising operating expenses.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more


The US firm, the company behind life’sDHA, recorded net income of US$7.6m for the six months to 30 April, down from $125.7m a year earlier.


The drop in profits came despite a rise in turnover. Sales reached $146.9m, up from $133.1m a year earlier.


CEO Steve Dubin expects sales and margins to rise in the second half of the year. “While Martek’s year-to-date earnings per share are currently below prior year levels, I expect Martek’s higher revenues and gross margin improvement in the second half of the year to generate full year earnings that exceed 2006 results,” Dubin said.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now